Altulaihi Bader A, Alharbi Khalid G, Alaboodi Talal A, Alkanhal Hamad M, Alobaid Meshal M, Aldraimly Maha A
Family Medicine, Ministry of National Guard-Health Affairs, King Abdullah International Medical Research Center, Riyadh, SAU.
Family Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, SAU.
Cureus. 2021 Sep 6;13(9):e17768. doi: 10.7759/cureus.17768. eCollection 2021 Sep.
Background The coronavirus disease 2019 (COVID-19), which is also known as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is an infection that is caused by the novel coronavirus. COVID-19 has severely affected the public health by causing more than 200 million cases and four million deaths worldwide. There are, presently, no specific antiviral treatments for COVID-19. As immunization is one of the most successful and cost-effective health interventions to prevent this infectious disease, a number of vaccines, around 112, have been developed. In Saudi Arabia, many vaccination campaigns have already started. There are currently four approved COVID-19 vaccines but only three are available for use in Saudi Arabia. Methods This was a cross-sectional study in which a web-based survey was distributed to medical students in their clinical years at the College of Medicine in King Saud bin Abdulaziz University, Riyadh, Saudi Arabia. A total of 209 questionnaires were distributed. The survey assessed the demographic data, perception towards COVID-19 vaccine, barriers and predictors for accepting COVID-19 vaccine. Results Two-hundred and four respondents completed the survey with a response rate of 96.7%. Overall, 118 of the participants were males and 86 were females. Sixty-six percent of our participants had taken the vaccine. Of those, males and females were distributed equally in half. Fifty-three percent of the participants who had taken the vaccine aged 21-23. This age group had a significant effect on acceptance of the vaccine. Most common deterrent to taking COVID-19 vaccine was safety issues despite not having a statistical significance. In terms of motivators, the majority thought that fear of getting COVID-19 infection was the most important motivator to taking COVID-19 vaccine, which was statistically significant as well. Conclusion In the setting of spreading COVID-19 infection, the vaccine is still the solution to halting infection spread. Based on our findings, we see that there was a high acceptance rate (66.2%) of COVID-19 vaccine.
背景 2019 冠状病毒病（COVID-19），也称为严重急性呼吸综合征冠状病毒 2（SARS-CoV-2），是一种由新型冠状病毒引起的感染。COVID-19 已在全球造成超过 2 亿例病例和 400 万人死亡，严重影响了公众健康。目前，尚无针对 COVID-19 的特异性抗病毒治疗方法。由于免疫接种是预防这种传染病最成功且最具成本效益的健康干预措施之一，因此已研发出约 112 种疫苗。在沙特阿拉伯，许多疫苗接种活动已经启动。目前有四种获批的 COVID-19 疫苗，但在沙特阿拉伯仅有三种可供使用。方法 这是一项横断面研究，通过网络调查向沙特阿拉伯利雅得阿卜杜勒阿齐兹国王大学医学院临床阶段的医学生发放问卷。共发放了 209 份问卷。该调查评估了人口统计学数据、对 COVID-19 疫苗的认知、接受 COVID-19 疫苗的障碍和预测因素。结果 204 名受访者完成了调查，回复率为 96.7%。总体而言，118 名参与者为男性，86 名为女性。66%的参与者接种了疫苗。其中，男性和女性各占一半。接种疫苗的参与者中有 53%年龄在 21 - 23 岁。这个年龄组对疫苗接种的接受度有显著影响。尽管没有统计学意义，但接种 COVID-19 疫苗最常见的阻碍因素是安全问题。在促使接种的因素方面，大多数人认为害怕感染 COVID-19 是接种 COVID-19 疫苗最重要的动力，这也具有统计学意义。结论 在 COVID-19 感染传播的情况下，疫苗仍然是阻止感染传播的解决办法。根据我们的研究结果，我们发现 COVID-19 疫苗的接受率较高（66.2%）。
